Literature DB >> 1224202

Inhibition of cell proliferation in renal failure and its significance to the uraemic syndrome: a review.

F T McDermott, A J Galbraith, R J Corlett.   

Abstract

The effect of acute and chronic renal failure on cell proliferation in rapidly dividing tissues has been examined in man and animal models. The evidence reviewed supports the hypothesis that renal failure results in a general inhibition of cell proliferation. Cell population kinetic studies of gastrointestinal and skin epithelia in experimental acute renal failure show a prolongation of the cell generation cycle. Less detailed investigations of other proliferative cell systems indicate an inhibitory effect on proliferation within the generative compartment of the erythroid series, lymphoid tissue, seminiferous epithelia and wound granulation tissue. This inhibition appears partly responsible for anaemia and impaired wound healing and may contribute to the abnormal immune responses, gastrointestinal tract lesions and male sterility found in renal failure.

Entities:  

Mesh:

Year:  1975        PMID: 1224202     DOI: 10.1177/003693307502000616

Source DB:  PubMed          Journal:  Scott Med J        ISSN: 0036-9330            Impact factor:   0.729


  4 in total

1.  Erythropoietin: the developing story.

Authors:  P M Cotes
Journal:  Br Med J (Clin Res Ed)       Date:  1988-03-19

2.  The anemia of chronic renal failure in sheep. Response to erythropoietin-rich plasma in vivo.

Authors:  J W Eschbach; J Mladenovic; J F Garcia; P W Wahl; J W Adamson
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

3.  The use of recombinant human erythropoietin in end stage renal disease.

Authors:  P J Conlon; J J Walshe; R O'Donnell; A O'Donohoe; R Spencer; J Donohoe; M Carmody
Journal:  Ir J Med Sci       Date:  1993-01       Impact factor: 1.568

4.  Myelodysplastic syndrome: the other cause of anemia in end-stage renal disease patients undergoing dialysis.

Authors:  Min-Yu Chang; Sheng-Fung Lin; Shih-Chi Wu; Wen-Chi Yang
Journal:  Sci Rep       Date:  2020-09-23       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.